Dow Up 0.07% Nasdaq Up 0.61%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.16 Down 0.01(0.85%) Nov 26, 4:00PM EST
Prev Close:1.17
Open:1.18
Bid:N/A
Ask:1.26 x 700
1y Target Est:2.81
Beta:1.36
Next Earnings Date:N/A
Day's Range:1.14 - 1.18
52wk Range:1.07 - 5.19
Volume:1,290,413
Avg Vol (3m):1,796,290
Market Cap:177.53M
P/E (ttm):N/A
EPS (ttm):-0.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZGNXDown 0.85%177.53M
AZNUp 0.34%93.35B
GSKUp 0.52%111.83B
PFEUp 2.07%195.95B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.67
Quarterly EPS Est (Dec-14) :-0.11
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback